Harrow Inc.
Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer
About Harrow Inc.
Harrow Inc is an eyecare pharmaceutical company engaged in the discovery, development, and commercialization of ophthalmic pharmaceutical products for the U.S. market. The company helps U.S. eyecare professionals preserve the gift of sight by making its comprehensive portfolio of prescription and non-prescription pharmaceutical products accessible and affordable to millions of Americans. Its operating segments are The Branded segment includes activities of the Company’s FDA-approved ophthalmology pharmaceutical products, including the out-licensing of rights to certain of branded products; and The ImprimisRx segment represents activities in the Company’s ophthalmology-focused pharmaceutical compounding business.
/ 
Others were interested in
See all stocksFrequently asked questions
To buy Harrow Inc. stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for Harrow Inc. by name or ticker, choose the number of shares, and place your order.
The ticker symbol for Harrow Inc. is HROW:xnas. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
Harrow Inc. has its primary listing on NASDAQ (Small cap). You can trade Harrow Inc. with a Saxo account, alongside thousands of other stocks worldwide.
Yes, Harrow Inc. is available to trade on SaxoInvestor and SaxoTraderGO. You can buy shares directly and include Harrow Inc. as part of a broader investment portfolio. Explore our SaxoInvestor platform.
Learn more about investing and trading at Saxo’s educational content hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures— so you can make more informed decisions when considering shares like Harrow Inc..